The primary endpoint was change from baseline in @-h weighted mean glucose ( WMG ) ; secondary endpoints included change from baseline in fasting plasma glucose ( FPG ) , insulin resistance ( Homeostatic Model Assessment -LSB- HOMA-IR -RSB- ) , insulin secretion ( HOMA - % B ) and body weight .